In addition, GlcN supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherosclerosis in apolipoprotein E-deficient mice, and these effects are independent of detectable changes in the levels of glucose, insulin and lipid in blood42. The gene discussed is INS; the disease is fatty liver disease.